CAITLIN NASS: Open Payments
NPI 1437273067 · MILLERSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,523 in 69 payments from 14 companies in 2025. Trend: 2023 $774 · 2024 $27,665 · 2025 $17,523
Speaker / faculty: $7,462Speaker / faculty: $4,756Travel & lodging: $2,868Food & beverage: $2,437
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 19 | $9,404 |
| Corcept Therapeutics | 15 | $5,119 |
| SANOFI-AVENTIS U.S. LLC | 4 | $1,686 |
| Novo Nordisk Inc | 13 | $385 |
| Insulet Corporation | 1 | $175 |
| Medtronic, Inc. | 4 | $163 |
| Abbott Laboratories | 4 | $161 |
| Lilly USA, LLC | 2 | $128 |
| BETA BIONICS, INC. | 1 | $114 |
| Tandem Diabetes Care, Inc. | 1 | $70 |
Products named: DEXCOM G7 GSS (161), Korlym, OMNIPOD, MINIMED 780G, FREESTYLE LIBRE 3, TZIELD, iLet Bionic Pancreas, ZEPBOUND.
Industry payments across MD — which companies pay providers there.
